πŸ‡ΊπŸ‡Έ FDA
Patent

US 6566116

Matrix metalloprotease

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6566116 (Matrix metalloprotease) held by Takeda Chemical Industries Ltd. expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P1/02